SynthesisBritish journal of clinical pharmacology2018

The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis.

Min Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.